International scientific guideline: Points to consider on multiplicity issues in clinical trials

About this guideline

Overseas effective date: 23 Jun 2005

Categories: Clinical efficacy and safety | Biostatistics

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.